You have access
Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast Cancer
MAI YAMADA, MAKOTO KUBO, HIDETAKA YAMAMOTO, NAMI YAMASHITA, MASAYA KAI, KAREN ZAGUIRRE, KAZUHISA KANESHIRO, AKIKO SHIMAZAKI, SAORI HAYASHI, HITOMI KAWAJI, MASAKI MORI, YOSHINAO ODA and MASAFUMI NAKAMURA
Anticancer Research August 2021, 41 (8) 4143-4149; DOI: https://doi.org/10.21873/anticanres.15217